Drug survival rates in patients with psoriasis after treatment with biologics
Author:
Affiliation:
1. Department of Dermatology; Jikei University School of Medicine; Tokyo Japan
Publisher
Wiley
Subject
Dermatology,General Medicine
Reference12 articles.
1. Interventions to enhance patient adherence to medication prescriptions: scientific review;McDonald;JAMA,2002
2. Pharmionics in dermatology: a review of topical medication adherence;Lee;Am J Clin Dermatol,2006
3. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic;Storm;J Am Acad Dermatol,2008
4. Japanese Infliximab Study i: infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial;Torii;J Dermatol Sci,2010
5. Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: efficacy and safety results from a Phase II/III randomized controlled study;Asahina;J Dermatol,2010
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Real-world biologic treatment patterns and healthcare resource utilization in psoriasis patients using an insurance claims database in Japan;Journal of Dermatological Treatment;2024-02-05
2. Sociodemographic and clinical characteristics associated with multiple biologic failure in psoriasis: A 2015-2022 prospective cohort analysis of the CorEvitas psoriasis registry;Journal of the American Academy of Dermatology;2023-11
3. Criteria used to define tumor necrosis factor-alpha inhibitors failure in patients with moderate-to-severe psoriasis: a systematic literature review;Annals of Medicine;2023-04-04
4. Survival rates of systemic interventions for psoriasis in the Western Japan Psoriasis Registry: A multicenter retrospective study;The Journal of Dermatology;2023-02-14
5. Comparison of Survival and Retention Rates between Infliximab and Adalimumab for Psoriasis: 10-Year Experience at a Single Tertiary Center;Dermatology;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3